Position in GILD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$259,755
-$34,315 QoQ
Shares Held
2,056
-2.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,761
of 2,266 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CHILTON INVESTMENT CO INC. holds $21,642,442 across 10 Drug Manufacturers - General names. GILD ranks #9 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,720 | $6,860,740 | |
| 2 | JNJ |
Johnson & Johnson
|
20,745 | $5,268,607 | |
| 3 | ABBV |
AbbVie Inc.
|
16,964 | $4,268,820 | |
| 4 | MRK |
Merck & Co., Inc.
|
13,953 | $1,792,960 | |
| 5 | AMGN |
Amgen Inc
|
3,302 | $1,195,720 | |
| 6 | AZN |
Astrazeneca PLC
|
5,268 | $998,918 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
7,562 | $435,722 | |
| 8 | NVS |
Novartis AG
|
2,250 | $352,620 |
All Filings in GILD
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $259,755 | 2,056 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $294,070 | 2,110 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $258,981 | 2,110 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||